Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
about
Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraThe rising challenge of non-AIDS-defining cancers in HIV-infected patientsScreening guidelines for non-AIDS defining cancers in HIV-infected individualsSevere morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortHIV tropism and decreased risk of breast cancerThe challenge of AIDS-related malignancies in sub-Saharan Africa.Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.Spectrum of cancer risk late after AIDS onset in the United States.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencingAge at cancer diagnosis among persons with AIDS in the United States.Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.Excess cancers among HIV-infected people in the United States.Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention.Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controlsInterleukin-6 and the IL-6 (-174) C/G polymorphism in breast pathologies and in HIV-infected patients.Cancer screening in patients infected with HIV.[HIV infection in patients with breast cancer in Guinea (West Africa)].Factors Associated with Adherence to Routine Screening Mammography in HIV-Infected Women.Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa.Caring for women living with HIV: gaps in the evidence.HIV and prostate cancer: a systematic review of the literature.Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer.Breast Cancer in HIV-Infected Patients: A Retrospective Single-Institution Study.Non-AIDS-defining cancers among HIV-infected patients.Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study.Deaths Due to Screenable Cancers Among People Living With HIV Infection, Florida, 2000-2014.Malignancies in women with HIV infection.Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness.Cancer screening in women living with HIV infection.Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
P2860
Q26797897-374B6534-AE86-484C-8459-381F0F9CCDB1Q26861496-161BFD5F-920D-4234-90F5-0968B36C1537Q27021899-AF236C38-775F-40F3-88E2-A65BB8335061Q28541356-A6F58C01-ED6A-43F1-A9A3-C85C54505845Q28744167-CD84B556-B0CF-42FD-9424-6BE00404000CQ33523293-EB2381D2-9D7E-4C5C-8AF2-AA03578A9F3DQ33636436-08D47B13-3014-498B-8BFF-37BEF7A32A14Q33859760-5D756090-C485-42C3-A12B-B1EFA0E6A3ABQ34049757-DA72BE11-0BC4-4F24-9A1F-668CFBBB3ABDQ34064264-A3E6EBBB-935E-4150-9793-5EDA97B7E9FDQ34612071-55D19FDD-87F7-41D8-84F5-B954AA453C3AQ34674367-AFB7DFC9-8499-407F-B8D8-05C6A4FF296BQ34766695-538D6E29-94D8-44A1-ABA5-A427BC92FC43Q34774173-789458E5-5C20-42E5-BB27-86164C9DC33AQ35102629-5DB1A882-50CE-44FC-B3C5-2CBB8FAD0684Q35204230-2E48E50B-77C5-430A-91D2-06EF04472644Q35783067-278BA882-5CAF-44D4-AEDB-E2D478B8512CQ35827357-75E81C23-62D4-4630-98B3-12F7DCD31674Q35838509-41BC9D6F-87C1-4FDB-AF80-BB3BB37F26FAQ36167713-729D3E66-AAD4-4356-A400-4F5B410B0E29Q36925715-B7B643E3-BC06-401B-8FBC-C4D6621C7052Q36997747-7B269901-A47D-4F01-816B-7FE32A10758BQ37212049-B17603AA-C6BF-4F68-A6B9-6B705F7F3572Q37246654-66FE139A-B945-46FB-B984-AE32E21CE602Q37649991-9DA4E7C3-D282-4F98-813A-74A10369302AQ37849047-C9CACEC2-B921-4503-A100-72FF98F67719Q38112573-47314B0B-B7F7-4BA3-9529-43848ECCC012Q38348630-9CD63ADB-6DB3-4474-BEF7-ED540C9864CEQ38656803-B253B53D-8E55-4C26-91B0-80150D76F4F5Q39010145-A1C9AAC8-5C23-4CBB-A4E2-004BF02B12DFQ41055765-DE9A6DC0-89C6-4154-9106-82DED3B72D35Q41918626-2C35B4A7-CD19-4CFE-A99B-ADF762B41396Q41929587-067E406C-1DED-4859-B6EB-643D17CE2217Q47614058-E281AEBA-E173-405E-BDC3-EFFB89C94C73Q52660669-131D2C34-F256-407A-931B-8FF9DD184361
P2860
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@ast
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@en
type
label
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@ast
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@en
prefLabel
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@ast
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@en
P2093
P2860
P356
P1476
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
@en
P2093
C S Rabkin
C Schairer
E A Engels
HIV/AIDS Cancer Match Study
J J Goedert
N A Hessol
T S McNeel
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603282
P407
P577
2006-07-25T00:00:00Z